Search research articles
Contact Us
Filters
Showing results (61-70 of 116) with videos related to
Page
of 12
Sort By:
Nature Medicine
|
November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
Marjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 13, 2006
Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis
Graham S Cooke, Sarah J Campbell, Jackson Sillah, et al.
The Journal of Infectious Diseases
|
March 27, 2012
Innovative trial designs are practical solutions for improving the treatment of tuberculosis
Patrick P J Phillips, Stephen H Gillespie, Martin Boeree, et al.
Antimicrobial Agents and Chemotherapy
|
June 19, 2013
Evaluation of initial and steady-state gatifloxacin pharmacokinetics and dose in pulmonary tuberculosis patients by using monte carlo simulations
Wynand Smythe, Corinne S Merle, Roxana Rustomjee, et al.
Plos One
|
February 23, 2019
Tuberculosis in Brazil and cash transfer programs: A longitudinal database study of the effect of cash transfer on cure rates
Barbara Reis-Santos, Priya Shete, Adelmo Bertolde, et al.
Antimicrobial Agents and Chemotherapy
|
January 19, 2012
A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patients
Wynand Smythe, Akash Khandelwal, Corinne Merle, et al.
Plos One
|
May 14, 2010
Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal
Christian Lienhardt, Katherine Fielding, Abdoul A Hane, et al.
Plos Medicine
|
January 4, 2017
Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model
Emily A Kendall, Sourya Shrestha, Ted Cohen, et al.
Emerging Infectious Diseases
|
April 20, 2019
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis
Lawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, et al.
Lancet (London, England)
|
March 28, 2015
WHO's new end TB strategy
Mukund Uplekar, Diana Weil, Knut Lonnroth, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 116) with videos related to
Sort By:
Page
of 12
Nature Medicine
|
November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
Marjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 13, 2006
Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis
Graham S Cooke, Sarah J Campbell, Jackson Sillah, et al.
The Journal of Infectious Diseases
|
March 27, 2012
Innovative trial designs are practical solutions for improving the treatment of tuberculosis
Patrick P J Phillips, Stephen H Gillespie, Martin Boeree, et al.
Antimicrobial Agents and Chemotherapy
|
June 19, 2013
Evaluation of initial and steady-state gatifloxacin pharmacokinetics and dose in pulmonary tuberculosis patients by using monte carlo simulations
Wynand Smythe, Corinne S Merle, Roxana Rustomjee, et al.
Plos One
|
February 23, 2019
Tuberculosis in Brazil and cash transfer programs: A longitudinal database study of the effect of cash transfer on cure rates
Barbara Reis-Santos, Priya Shete, Adelmo Bertolde, et al.
Antimicrobial Agents and Chemotherapy
|
January 19, 2012
A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patients
Wynand Smythe, Akash Khandelwal, Corinne Merle, et al.
Plos One
|
May 14, 2010
Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal
Christian Lienhardt, Katherine Fielding, Abdoul A Hane, et al.
Plos Medicine
|
January 4, 2017
Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model
Emily A Kendall, Sourya Shrestha, Ted Cohen, et al.
Emerging Infectious Diseases
|
April 20, 2019
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis
Lawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, et al.
Lancet (London, England)
|
March 28, 2015
WHO's new end TB strategy
Mukund Uplekar, Diana Weil, Knut Lonnroth, et al.
Page
of 12